IVERIC bio (ISEE) Misses Q4 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to IVERIC bio (ISEE) Misses Q4 EPS by 5c

Iveric Bio Reports Fourth Quarter and Full Year 2021 Operational Highlights and Financial Results

February 24, 2022 6:30 AM EST

- Zimura® GATHER2 Topline Data Expected in the Second Half of 2022 -

- GATHER2 Trial Completion at 84% for Year One; Patient Retention Continues to Exceed Expectations with a 12-Month Injection Fidelity Rate Target Greater than 90%

- Internal Efforts for Preparation of a New Drug Application (NDA) Ongoing -

- Zimura Phase 3 Clinical Trial for Intermediate AMD to Initiate in Second Half of 2022

- Conference Call and Webcast Today, February 24, 2022, at 8:00 a.m. ET

PARSIPPANY, N.J.--(BUSINESS... More